Macular degeneration: open trials in Israel

9 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
The Lady Davis Carmel Medical Center /ID# 265618, Haifa · Edith Wolfson Medical Center /ID# 266304, Holon · Hadassah Medical Center-Hebrew University /ID# 264300, Jerusalem · Rabin Medical Center /ID# 266449, Petah Tikva · The Chaim Sheba Medical Center /ID# 264700, Ramat Gan · Kaplan Medical Center /ID# 264399, Rehovot · Tel Aviv Sourasky Medical Center /ID# 266246, Tel Aviv · Yitzhak Shamir Medical Center /ID# 275679, Tsrifin
Registry updated 2026-10-29
NCT03683251
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Rambam Medical Center, Haifa · Hadassah MC, Jerusalem · Meir Medical Center, Kfar Saba · Rabin MC, Petah Tikva · Kaplan Medical Center, Rehovot · Tel-Aviv Sourasky MC, Tel Aviv
Registry updated 2026-10-27
NCT06659549
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Trial Treatment · Phase 2 · Galimedix Therapeutics Inc
Hadassah medical Center, Jerusalem · Tel Aviv Medical Center, Tel Aviv
Registry updated 2026-10-22
NCT07064759
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Trial Treatment · Phase 3 · 4D Molecular Therapeutics
Rambam Health Care Campus, Haifa · Carmel Medical Center, Haifa · Wolfson Medical Center, Holon · Shaare Zedek Medical Center, Jerusalem · Hadassah Medical Center - Ein Kerem, Jerusalem · Sheba medical center, Ramat Gan · Kaplan Medical Center, Rehovot · Tel Aviv Medical Center, Tel Aviv
Registry updated 2026-10-19
NCT05626114
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Trial Treatment · Phase 2 · Genentech, Inc.
Hadassah MC, Jerusalem · Tel-Aviv Sourasky MC, Tel Aviv
Registry updated 2026-10-14
NCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Barzilai Medical Center, Ashkelon · Rambam Health Corporation (Site 706), Haifa · Carmel Medical Center (Site 704), Haifa · Hadassah Medical Center Opthalmology Department (Site 701), Jerusalem · Rabin Medical Center (Site 700), Petah Tikva · Sheba Medical Center (Site 707), Ramat Gan · Kaplan Medical Center Ophthalmology Department (Site 705), Rehovot · Shamir Medical Center (Site 703), Tsrifin
Registry updated 2026-10-02
NCT06765980
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 1/2 · Kriya Therapeutics, Inc.
Tel Aviv
Registry updated 2026-08-10
NCT07660640
Long-Term Follow Up of VOY-101 Non-nAMD Extension Study
Research · Perceive Biotherapeutics, Inc.
Sourasky Medical Center - Ichilov, Tel Aviv
Registry updated 2026-06-22
NCT00874783
Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Research · Hadassah Medical Organization
Hadassah Ein Kerem, Jerusalem
Registry updated 2025-03-04

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error